New product [Regulatives / Guidelines]

posted by ping4santosh  – India, 2020-03-11 15:34 (322 d 21:00 ago) – Posting: # 21256
Views: 3,208

» » Both the APIs are registered as individual products in market and we are just combining both. Why would you call it as a new product [...]
»
» Because that's what it is. You have to distinguish API and formulation. This will be a new combination of two existing API.

Dear Ohlbe,

Both the APIs are registered and marketed as separate formulation. We are mixing these two at same ratio into one formulation without adding any new excipients. I don't know why will it be considered as a new product. Can you guide me please?


Edit: Please don’t shout[Helmut]

Complete thread:

Activity
 Admin contact
21,317 posts in 4,447 threads, 1,489 registered users;
online 4 (0 registered, 4 guests [including 2 identified bots]).
Forum time: Thursday 12:35 UTC (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5